Today Chancellor of the Exchequer George Osborne announced the recipients of our Clinical Research Capabilities and Technologies Initiative, with 23 projects receiving a total of just over £170m. But what exactly are these ‘capabilities’, what do we hope to achieve, and where did all that money come from? Katherine Nightingale takes a closer look.
What do we mean by clinical research capabilities?
It’s about new technologies for clinical research. We’re all familiar with the idea of clinical research being about clinical trials to assess drugs, devices and diagnostics in people. Clinical research is often seen as the end of the ‘pipeline’ from making discoveries in the laboratory to helping patients, but that’s not the whole story.
We want to make clinical research in the UK also about studying disease at the molecular, cellular, organ and whole-body level ― and to do that researchers need new tools. This includes better body-imaging equipment, new technology for monitoring physiology, and ways of analysing the intricacies of disease in cells and tissues. Doing this needs big pieces of kit, as well as resources for building on the equipment in the future and using it in new ways.
Discoveries made in this way might then be fed back ‘into the lab’ or go on to influence further clinical research. The aim is that by funding these technologies, we’ll build on existing infrastructure, and speed up innovation by allowing researchers to explore new areas. Read more